We’re #8! PTO Ranks The Economic Power Of Pharma’s Patents
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmaceuticals falls below computers, communications and electrical equipment in “patent intensity” – the ratio of patents to jobs – according to a Patent and Trademark Office report on the importance of intellectual property to the U.S. economy.
You may also be interested in...
AstraZeneca To Lay Off 24% Of U.S. Sales Force As Of Feb. 2012
The company isn’t providing much detail on reasons or commercial strategy going forward, but its long-term outlook, particularly in western markets, is uninspiring, burdened by generic competition and a mixed R&D track record.
Novartis Cuts 2,000 Jobs In Switzerland And U.S., Pricing Pressures To Blame
Novartis intends to improve productivity and absorb pricing pressures by closing two Swiss manufacturing facilities and transferring some research to the U.S.
Patent Reform Speeds Drug Development, At Least At The Signing Ceremony
President Obama announce seven initiatives to help move ideas from the lab to market as he signs the Leahy-Smith America Invents Act.